Eric Lippert
0000-0002-2312-6584
7 papers found
Refreshing results…
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study
Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation
Anti-Glucosylsphingosine Autoimmunity, JAK2V617F-Dependent Interleukin-1β and JAK2V617F-Independent Cytokines in Myeloproliferative Neoplasms
Long-term follow-up of JAK2 exon 12 polycythemia vera: a French Intergroup of Myeloproliferative Neoplasms (FIM) study
Sequential mutational evaluation of CALR ‐mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression
Molecular monitoring of patients with ETV6-PDGFRB rearrangement: Implications for therapeutic adaptation
Missing publications? Search for publications with a matching author name.